Publication date: Aug 10, 2019
This paper describes a patient who presented with treatment-resistant depression with comorbid anxiety symptoms in the context of Huntington’s disease (HD) and developed worsening movement disorder symptoms after commencing electroconvulsive therapy (ECT) for depression. The aim of this case report is to provide medical practitioners with a greater awareness of the possibility of worsening movement disorders when using ECT for depression in a patient with HD.
Abeysundera, H., Campbell, A., and Sarma, S. Worsening of movement disorder following treatment with electroconvulsive therapy in a patient with Huntington’s disease. 06624. 2019 BMJ Case Rep (12):8.
- Cdk5 Protein Activity in Brain Linked to Depression, Potentially Even Treatment, in Huntington’s, Mouse Study Suggests
- Positive Affect and Well-Being in Huntington’s Disease Moderates the Association Between Functional Impairment and HRQOL Outcomes.
- Huntington’s Disease Treatment Market Adopts Innovation to Stay Competitive Forecast 2026
- Clinical phenotype in carriers of intermediate alleles in the huntingtin gene.
- Huntington’s disease and the benefits of exercise